Lutrate® Depot 3.75 mg

Leuprolide Acetate

Lutrate® Depot 3.75 mg is a proprietary depot formulation of Leuprolide Acetate, an LHRH agonist, used every month for three months for pallitative treatment of advanced prostate cancer. The product is based on a patented formulation.

Lutrate® Depot 22.5 mg

Leuprolide Acetate

Lutrate® Depot 22.5 mg is a proprietary depot formulation of Leuprolide Acetate, an LHRH agonist, used once in 3 month for pallitative treatment of advanced prostate cancer. The product is based on patented formulation.

  Awaiting DCGI approval

For more information on Lutrate®
Please refer http://gp-pharm.com/en/products or
Contact your local sales representative or
Email us at info@sayretherapeutics.com